Get started
Author

Molly Fisher Thomas

Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
2020 · Ellen Shrock, Eric Fujimura, et al. · Science · 678
PDF
MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-γ Production in Helper T Cells
2011 · David F. Steiner, Molly F. Thomas, et al. · Immunity · 365
PDF
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
2021 · Michael R. Filbin, Arnav Mehta, et al. · Cell Reports Medicine · 313
PDF
Profound Treg perturbations correlate with COVID-19 severity
2021 · Silvia Galván-Peña, Juliette Leon, et al. · Proceedings of the National Academy of Sciences · 185
PDF
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
2021 · Shira Weingarten-Gabbay, Susan Klaeger, et al. · Cell · 147
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
2021 · Yijia Li, Alexis M. Schneider, et al. · Journal of Clinical Investigation · 127
PDF
Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
2018 · Kerry Reynolds, Molly Thomas, et al. · The Oncologist · 111
A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing
2011 · Joshua E. Babiarz, Ruby Hsu, et al. · RNA · 109
PDF
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19
2021 · Daniel E. Leisman, Arnav Mehta, et al. · American Journal of Respiratory and Critical Care Medicine · 104
Immune responses in checkpoint myocarditis across heart, blood and tumour
2024 · Steven M. Blum, Daniel A. Zlotoff, et al. · Nature · 86
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
2024 · Molly Fisher Thomas, Kamil Slowikowski, et al. · Nature Medicine · 85
PDF
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
2021 · Paulina Kaplonek, Chuangqi Wang, et al. · Science Immunology · 76
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients
2022 · Thomas J. LaSalle, Anna L.K. Gonye, et al. · Cell Reports Medicine · 70
Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function
2012 · Molly F. Thomas, Sarah Abdul-Wajid, et al. · Blood · 68
PDF
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018
2021 · Gabriel E. Molina, Leyre Zubiri, et al. · The Oncologist · 53
PDF
Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways
2014 · Molly F. Thomas, Noelle D. L’Etoile, et al. · Trends in Genetics · 40
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records
2024 · Virginia H. Sun, Julius C. Heemelaar, et al. · Journal of Clinical Oncology · 38
PDF
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
2021 · Leyre Zubiri, Gabriel E Molina, et al. · Journal for ImmunoTherapy of Cancer · 38
PDF
Construction of Small RNA cDNA Libraries for Deep Sequencing
2010 · Molly F. Thomas, K. Mark Ansel · Methods in molecular biology · 31
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor
2023 · Steven M. Blum, Daniel A. Zlotoff, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 13
PDF
Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: A tsunami is coming, but are we ready?
2018 · Kerry Lynn Reynolds, Justine Vanessa Cohen, et al. · Journal of Clinical Oncology · 13
Cost of inpatient admissions for immune-related adverse effects from immune checkpoint inhibitor therapy: A single center experience.
2018 · Jacqueline N. Chu, Jin G. Choi, et al. · Journal of Clinical Oncology · 11
Severe immune-related adverse effects (irAE) requiring hospital admission in patients treated with immune checkpoint inhibitors for advanced malignancy: Temporal trends and clinical significance.
2018 · Kerry Lynn Reynolds, Justine Vanessa Cohen, et al. · Journal of Clinical Oncology · 8
Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humans
2023 · Long Guo, Smrithi Salian, et al. · The American Journal of Human Genetics · 5
PDF
A Multicenter Study of Left Ventricular Assist Device-Related Gastrointestinal Bleeding
2022 · Joseph Dailey, Long H. Nguyen, et al. · Clinical and Translational Gastroenterology · 5
Works count: 62
Citation count: 2,800
H-index: 19
I10-index: 22
Year
Topic
Type